134 related articles for article (PubMed ID: 18570153)
1. FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.
Goscinski MA; Suo Z; Flørenes VA; Vlatkovic L; Nesland JM; Giercksky KE
Ultrastruct Pathol; 2008; 32(3):89-96. PubMed ID: 18570153
[TBL] [Abstract][Full Text] [Related]
2. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE
Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclin E in dysplasia, carcinoma, and nonmalignant lesions of Barrett esophagus.
Sarbia M; Bektas N; Müller W; Heep H; Borchard F; Gabbert HE
Cancer; 1999 Dec; 86(12):2597-601. PubMed ID: 10594854
[TBL] [Abstract][Full Text] [Related]
4. Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma.
Nomiya T; Nemoto K; Miyachi H; Fujimoto K; Takahashi C; Takeda K; Matushita H; Ogawa Y; Takai Y; Yamada S
Anticancer Res; 2002; 22(5):2913-6. PubMed ID: 12530017
[TBL] [Abstract][Full Text] [Related]
5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
6. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
Castelló R; Landete JM; España F; Vázquez C; Fuster C; Almenar SM; Ramón LA; Radtke KP; Estellés A
Thromb Res; 2007; 120(5):753-62. PubMed ID: 17258797
[TBL] [Abstract][Full Text] [Related]
7. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
Evangelou K; Kotsinas A; Mariolis-Sapsakos T; Giannopoulos A; Tsantoulis PK; Constantinides C; Troupis TG; Salmas M; Kyroudis A; Kittas C; Gorgoulis VG
J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of fibroblast activation protein in patients with colon cancer.
Henry LR; Lee HO; Lee JS; Klein-Szanto A; Watts P; Ross EA; Chen WT; Cheng JD
Clin Cancer Res; 2007 Mar; 13(6):1736-41. PubMed ID: 17363526
[TBL] [Abstract][Full Text] [Related]
9. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
10. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
11. Loss of MAL expression in precancerous lesions of the esophagus.
Mimori K; Nishida K; Nakamura Y; Ieta K; Yoshikawa Y; Sasaki A; Ishii H; Alonso MA; Mori M
Ann Surg Oncol; 2007 May; 14(5):1670-7. PubMed ID: 17151798
[TBL] [Abstract][Full Text] [Related]
12. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
[TBL] [Abstract][Full Text] [Related]
13. Expression of stromal cell markers in distinct compartments of human skin cancers.
Huber MA; Kraut N; Schweifer N; Dolznig H; Peter RU; Schubert RD; Scharffetter-Kochanek K; Pehamberger H; Garin-Chesa P
J Cutan Pathol; 2006 Feb; 33(2):145-55. PubMed ID: 16420310
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Cohen SJ; Alpaugh RK; Palazzo I; Meropol NJ; Rogatko A; Xu Z; Hoffman JP; Weiner LM; Cheng JD
Pancreas; 2008 Aug; 37(2):154-8. PubMed ID: 18665076
[TBL] [Abstract][Full Text] [Related]
15. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
[TBL] [Abstract][Full Text] [Related]
16. Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.
Steiner E; Pollow K; Hasenclever D; Schormann W; Hermes M; Schmidt M; Puhl A; Brulport M; Bauer A; Petry IB; Koelbl H; Hengstler JG
Gynecol Oncol; 2008 Mar; 108(3):569-76. PubMed ID: 18222533
[TBL] [Abstract][Full Text] [Related]
17. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma.
Li Y; Wo JM; Su RR; Ray MB; Martin RC
Ann Surg Oncol; 2007 Jul; 14(7):2045-55. PubMed ID: 17473952
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus.
Piaggi S; Marchi S; Ciancia E; Debortoli N; Lazzarotti A; Saviozzi M; Raggi C; Fierabracci V; Visvikis A; Bisgaard HC; Casini AF; Paolicchi A
Oncol Rep; 2009 Feb; 21(2):283-7. PubMed ID: 19148497
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics study of esophageal adenocarcinoma.
Zhang J; Liu L; Wei S; Nagana Gowda GA; Hammoud Z; Kesler KA; Raftery D
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):469-75, 475.e1-4. PubMed ID: 20880550
[TBL] [Abstract][Full Text] [Related]
20. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.
Paweletz CP; Ornstein DK; Roth MJ; Bichsel VE; Gillespie JW; Calvert VS; Vocke CD; Hewitt SM; Duray PH; Herring J; Wang QH; Hu N; Linehan WM; Taylor PR; Liotta LA; Emmert-Buck MR; Petricoin EF
Cancer Res; 2000 Nov; 60(22):6293-7. PubMed ID: 11103786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
